Table 1 Discovery and replication sample demographics.
From: Y disruption, autosomal hypomethylation and poor male lung cancer survival
Normal n | Tumour n | Age µ (sd) | Sex % Male (n M/F) | Tumour stage n IA/IB/II/IIA/IIB/III/IIIA/IIIB/IV (NR) | Smoking n NS/EX/CS (NR) | Deceased n T/F (NR) | |
|---|---|---|---|---|---|---|---|
Discovery | |||||||
LUAD | 83 | 92 | 68.46 (8.92) | 49.14% (86/89) | 54/37/0/22/12/0/42/0/7 (1) | 23/90/58 (4) | 77/95 (3) |
LUSC | 30 | 32 | 69.63 (6.79) | 64.52% (40/22) | 22/12/0/9/11/0/8/0/0 (0) | 0/39/23 (0) | 33/29 (0) |
Overall | 113 | 124 | 68.77 (8.42) | 53.16% (126/111) | 76/49/0/31/23/0/50/0/7 (1) | 23/129/81 (4) | 110/124 (3) |
Replication | |||||||
LUAD | 38 | 41 | 64.38 (8.6) | 36.71% (29/50) | 14/20/0/21/7/7/2/0/0 (8) | – | – |
LUSC | 21 | 23 | 68.2 (7.49) | 75% (33/11) | 5/13/2/6/6/9/1/2/0 (0) | – | – |
Overall | 59 | 64 | 65.75 (8.4) | 50.41% (62/61) | 19/33/2/27/13/16/3/2/0 (8) | – | – |
